世界のアンドロゲン性脱毛症治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Androgenic Alopecia Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5580
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、108ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、アンドロゲン性脱毛症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（医学、外科手術、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・アンドロゲン性脱毛症治療薬の市場動向
・企業の競争状況、市場シェア
・アンドロゲン性脱毛症治療薬の種類別市場規模と予測2016-2027（医学、外科手術、その他）
・アンドロゲン性脱毛症治療薬の用途別市場規模と予測2016-2027（病院、診療所、その他）
・アンドロゲン性脱毛症治療薬の北米市場規模2016-2027（アメリカ、カナダ）
・アンドロゲン性脱毛症治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・アンドロゲン性脱毛症治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・アンドロゲン性脱毛症治療薬の中南米市場規模2016-2027（メキシコ、ブラジル）
・アンドロゲン性脱毛症治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Johnson & Johnson、Merck、GlaxoSmithKline、Astellas Pharma、Cipla、Almirall、Sun Pharma、Reddy's Laboratories、Concert Pharmaceuticals、RiverTown Therapeutics、Brickell Biotech、BiologicsMD、Aclaris Therapeutics）
・結論

Androgenic Alopecia refers to the phenomenon of hair loss, including natural hair loss and pathological hair loss caused by various reasons.

Market Analysis and Insights: Global Androgenic Alopecia Therapeutics Market
The global Androgenic Alopecia Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Androgenic Alopecia Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Androgenic Alopecia Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Androgenic Alopecia Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Androgenic Alopecia Therapeutics market.

Global Androgenic Alopecia Therapeutics Scope and Market Size
Androgenic Alopecia Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Androgenic Alopecia Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Medicine
Surgery
Other

Segment by Application
Hospital
Clinic
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Johnson & Johnson
Merck
GlaxoSmithKline
Astellas Pharma
Cipla
Almirall
Sun Pharma
Reddy’s Laboratories
Concert Pharmaceuticals
RiverTown Therapeutics
Brickell Biotech
BiologicsMD
Aclaris Therapeutics

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Androgenic Alopecia Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Medicine
1.2.3 Surgery
1.2.4 Other
1.3 Market by Application
1.3.1 Global Androgenic Alopecia Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Androgenic Alopecia Therapeutics Market Perspective (2016-2027)
2.2 Androgenic Alopecia Therapeutics Growth Trends by Regions
2.2.1 Androgenic Alopecia Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Androgenic Alopecia Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Androgenic Alopecia Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Androgenic Alopecia Therapeutics Industry Dynamic
2.3.1 Androgenic Alopecia Therapeutics Market Trends
2.3.2 Androgenic Alopecia Therapeutics Market Drivers
2.3.3 Androgenic Alopecia Therapeutics Market Challenges
2.3.4 Androgenic Alopecia Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Androgenic Alopecia Therapeutics Players by Revenue
3.1.1 Global Top Androgenic Alopecia Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Androgenic Alopecia Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Androgenic Alopecia Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Androgenic Alopecia Therapeutics Revenue
3.4 Global Androgenic Alopecia Therapeutics Market Concentration Ratio
3.4.1 Global Androgenic Alopecia Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Androgenic Alopecia Therapeutics Revenue in 2020
3.5 Androgenic Alopecia Therapeutics Key Players Head office and Area Served
3.6 Key Players Androgenic Alopecia Therapeutics Product Solution and Service
3.7 Date of Enter into Androgenic Alopecia Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Androgenic Alopecia Therapeutics Breakdown Data by Type
4.1 Global Androgenic Alopecia Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Androgenic Alopecia Therapeutics Forecasted Market Size by Type (2022-2027)

5 Androgenic Alopecia Therapeutics Breakdown Data by Application
5.1 Global Androgenic Alopecia Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Androgenic Alopecia Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Androgenic Alopecia Therapeutics Market Size (2016-2027)
6.2 North America Androgenic Alopecia Therapeutics Market Size by Type
6.2.1 North America Androgenic Alopecia Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Androgenic Alopecia Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Androgenic Alopecia Therapeutics Market Size by Type (2016-2027)
6.3 North America Androgenic Alopecia Therapeutics Market Size by Application
6.3.1 North America Androgenic Alopecia Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Androgenic Alopecia Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Androgenic Alopecia Therapeutics Market Size by Application (2016-2027)
6.4 North America Androgenic Alopecia Therapeutics Market Size by Country
6.4.1 North America Androgenic Alopecia Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Androgenic Alopecia Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Androgenic Alopecia Therapeutics Market Size (2016-2027)
7.2 Europe Androgenic Alopecia Therapeutics Market Size by Type
7.2.1 Europe Androgenic Alopecia Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Androgenic Alopecia Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Androgenic Alopecia Therapeutics Market Size by Type (2016-2027)
7.3 Europe Androgenic Alopecia Therapeutics Market Size by Application
7.3.1 Europe Androgenic Alopecia Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Androgenic Alopecia Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Androgenic Alopecia Therapeutics Market Size by Application (2016-2027)
7.4 Europe Androgenic Alopecia Therapeutics Market Size by Country
7.4.1 Europe Androgenic Alopecia Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Androgenic Alopecia Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Androgenic Alopecia Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Androgenic Alopecia Therapeutics Market Size by Type
8.2.1 Asia-Pacific Androgenic Alopecia Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Androgenic Alopecia Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Androgenic Alopecia Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Androgenic Alopecia Therapeutics Market Size by Application
8.3.1 Asia-Pacific Androgenic Alopecia Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Androgenic Alopecia Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Androgenic Alopecia Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Androgenic Alopecia Therapeutics Market Size by Region
8.4.1 Asia-Pacific Androgenic Alopecia Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Androgenic Alopecia Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Androgenic Alopecia Therapeutics Market Size (2016-2027)
9.2 Latin America Androgenic Alopecia Therapeutics Market Size by Type
9.2.1 Latin America Androgenic Alopecia Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Androgenic Alopecia Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Androgenic Alopecia Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Androgenic Alopecia Therapeutics Market Size by Application
9.3.1 Latin America Androgenic Alopecia Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Androgenic Alopecia Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Androgenic Alopecia Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Androgenic Alopecia Therapeutics Market Size by Country
9.4.1 Latin America Androgenic Alopecia Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Androgenic Alopecia Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Androgenic Alopecia Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Androgenic Alopecia Therapeutics Market Size by Type
10.2.1 Middle East & Africa Androgenic Alopecia Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Androgenic Alopecia Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Androgenic Alopecia Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Androgenic Alopecia Therapeutics Market Size by Application
10.3.1 Middle East & Africa Androgenic Alopecia Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Androgenic Alopecia Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Androgenic Alopecia Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Androgenic Alopecia Therapeutics Market Size by Country
10.4.1 Middle East & Africa Androgenic Alopecia Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Androgenic Alopecia Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Androgenic Alopecia Therapeutics Introduction
11.1.4 Johnson & Johnson Revenue in Androgenic Alopecia Therapeutics Business (2016-2021)
11.1.5 Johnson & Johnson Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Androgenic Alopecia Therapeutics Introduction
11.2.4 Merck Revenue in Androgenic Alopecia Therapeutics Business (2016-2021)
11.2.5 Merck Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Androgenic Alopecia Therapeutics Introduction
11.3.4 GlaxoSmithKline Revenue in Androgenic Alopecia Therapeutics Business (2016-2021)
11.3.5 GlaxoSmithKline Recent Development
11.4 Astellas Pharma
11.4.1 Astellas Pharma Company Details
11.4.2 Astellas Pharma Business Overview
11.4.3 Astellas Pharma Androgenic Alopecia Therapeutics Introduction
11.4.4 Astellas Pharma Revenue in Androgenic Alopecia Therapeutics Business (2016-2021)
11.4.5 Astellas Pharma Recent Development
11.5 Cipla
11.5.1 Cipla Company Details
11.5.2 Cipla Business Overview
11.5.3 Cipla Androgenic Alopecia Therapeutics Introduction
11.5.4 Cipla Revenue in Androgenic Alopecia Therapeutics Business (2016-2021)
11.5.5 Cipla Recent Development
11.6 Almirall
11.6.1 Almirall Company Details
11.6.2 Almirall Business Overview
11.6.3 Almirall Androgenic Alopecia Therapeutics Introduction
11.6.4 Almirall Revenue in Androgenic Alopecia Therapeutics Business (2016-2021)
11.6.5 Almirall Recent Development
11.7 Sun Pharma
11.7.1 Sun Pharma Company Details
11.7.2 Sun Pharma Business Overview
11.7.3 Sun Pharma Androgenic Alopecia Therapeutics Introduction
11.7.4 Sun Pharma Revenue in Androgenic Alopecia Therapeutics Business (2016-2021)
11.7.5 Sun Pharma Recent Development
11.8 Reddy’s Laboratories
11.8.1 Reddy’s Laboratories Company Details
11.8.2 Reddy’s Laboratories Business Overview
11.8.3 Reddy’s Laboratories Androgenic Alopecia Therapeutics Introduction
11.8.4 Reddy’s Laboratories Revenue in Androgenic Alopecia Therapeutics Business (2016-2021)
11.8.5 Reddy’s Laboratories Recent Development
11.9 Concert Pharmaceuticals
11.9.1 Concert Pharmaceuticals Company Details
11.9.2 Concert Pharmaceuticals Business Overview
11.9.3 Concert Pharmaceuticals Androgenic Alopecia Therapeutics Introduction
11.9.4 Concert Pharmaceuticals Revenue in Androgenic Alopecia Therapeutics Business (2016-2021)
11.9.5 Concert Pharmaceuticals Recent Development
11.10 RiverTown Therapeutics
11.10.1 RiverTown Therapeutics Company Details
11.10.2 RiverTown Therapeutics Business Overview
11.10.3 RiverTown Therapeutics Androgenic Alopecia Therapeutics Introduction
11.10.4 RiverTown Therapeutics Revenue in Androgenic Alopecia Therapeutics Business (2016-2021)
11.10.5 RiverTown Therapeutics Recent Development
11.11 Brickell Biotech
11.11.1 Brickell Biotech Company Details
11.11.2 Brickell Biotech Business Overview
11.11.3 Brickell Biotech Androgenic Alopecia Therapeutics Introduction
11.11.4 Brickell Biotech Revenue in Androgenic Alopecia Therapeutics Business (2016-2021)
11.11.5 Brickell Biotech Recent Development
11.12 BiologicsMD
11.12.1 BiologicsMD Company Details
11.12.2 BiologicsMD Business Overview
11.12.3 BiologicsMD Androgenic Alopecia Therapeutics Introduction
11.12.4 BiologicsMD Revenue in Androgenic Alopecia Therapeutics Business (2016-2021)
11.12.5 BiologicsMD Recent Development
11.13 Aclaris Therapeutics
11.13.1 Aclaris Therapeutics Company Details
11.13.2 Aclaris Therapeutics Business Overview
11.13.3 Aclaris Therapeutics Androgenic Alopecia Therapeutics Introduction
11.13.4 Aclaris Therapeutics Revenue in Androgenic Alopecia Therapeutics Business (2016-2021)
11.13.5 Aclaris Therapeutics Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Androgenic Alopecia Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Medicine
Table 3. Key Players of Surgery
Table 4. Key Players of Other
Table 5. Global Androgenic Alopecia Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Androgenic Alopecia Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Androgenic Alopecia Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Androgenic Alopecia Therapeutics Market Share by Regions (2016-2021)
Table 9. Global Androgenic Alopecia Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Androgenic Alopecia Therapeutics Market Share by Regions (2022-2027)
Table 11. Androgenic Alopecia Therapeutics Market Trends
Table 12. Androgenic Alopecia Therapeutics Market Drivers
Table 13. Androgenic Alopecia Therapeutics Market Challenges
Table 14. Androgenic Alopecia Therapeutics Market Restraints
Table 15. Global Androgenic Alopecia Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Androgenic Alopecia Therapeutics Market Share by Players (2016-2021)
Table 17. Global Top Androgenic Alopecia Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Androgenic Alopecia Therapeutics as of 2020)
Table 18. Ranking of Global Top Androgenic Alopecia Therapeutics Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Androgenic Alopecia Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Androgenic Alopecia Therapeutics Product Solution and Service
Table 22. Date of Enter into Androgenic Alopecia Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Androgenic Alopecia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Androgenic Alopecia Therapeutics Revenue Market Share by Type (2016-2021)
Table 26. Global Androgenic Alopecia Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Androgenic Alopecia Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Androgenic Alopecia Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Androgenic Alopecia Therapeutics Revenue Market Share by Application (2016-2021)
Table 30. Global Androgenic Alopecia Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Androgenic Alopecia Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Androgenic Alopecia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Androgenic Alopecia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Androgenic Alopecia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Androgenic Alopecia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Androgenic Alopecia Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Androgenic Alopecia Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Androgenic Alopecia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Androgenic Alopecia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Androgenic Alopecia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Androgenic Alopecia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Androgenic Alopecia Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Androgenic Alopecia Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Androgenic Alopecia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Androgenic Alopecia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Androgenic Alopecia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Androgenic Alopecia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Androgenic Alopecia Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Androgenic Alopecia Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Androgenic Alopecia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Androgenic Alopecia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Androgenic Alopecia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Androgenic Alopecia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Androgenic Alopecia Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Androgenic Alopecia Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Androgenic Alopecia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Androgenic Alopecia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Androgenic Alopecia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Androgenic Alopecia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Androgenic Alopecia Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Androgenic Alopecia Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 62. Johnson & Johnson Company Details
Table 63. Johnson & Johnson Business Overview
Table 64. Johnson & Johnson Androgenic Alopecia Therapeutics Product
Table 65. Johnson & Johnson Revenue in Androgenic Alopecia Therapeutics Business (2016-2021) & (US$ Million)
Table 66. Johnson & Johnson Recent Development
Table 67. Merck Company Details
Table 68. Merck Business Overview
Table 69. Merck Androgenic Alopecia Therapeutics Product
Table 70. Merck Revenue in Androgenic Alopecia Therapeutics Business (2016-2021) & (US$ Million)
Table 71. Merck Recent Development
Table 72. GlaxoSmithKline Company Details
Table 73. GlaxoSmithKline Business Overview
Table 74. GlaxoSmithKline Androgenic Alopecia Therapeutics Product
Table 75. GlaxoSmithKline Revenue in Androgenic Alopecia Therapeutics Business (2016-2021) & (US$ Million)
Table 76. GlaxoSmithKline Recent Development
Table 77. Astellas Pharma Company Details
Table 78. Astellas Pharma Business Overview
Table 79. Astellas Pharma Androgenic Alopecia Therapeutics Product
Table 80. Astellas Pharma Revenue in Androgenic Alopecia Therapeutics Business (2016-2021) & (US$ Million)
Table 81. Astellas Pharma Recent Development
Table 82. Cipla Company Details
Table 83. Cipla Business Overview
Table 84. Cipla Androgenic Alopecia Therapeutics Product
Table 85. Cipla Revenue in Androgenic Alopecia Therapeutics Business (2016-2021) & (US$ Million)
Table 86. Cipla Recent Development
Table 87. Almirall Company Details
Table 88. Almirall Business Overview
Table 89. Almirall Androgenic Alopecia Therapeutics Product
Table 90. Almirall Revenue in Androgenic Alopecia Therapeutics Business (2016-2021) & (US$ Million)
Table 91. Almirall Recent Development
Table 92. Sun Pharma Company Details
Table 93. Sun Pharma Business Overview
Table 94. Sun Pharma Androgenic Alopecia Therapeutics Product
Table 95. Sun Pharma Revenue in Androgenic Alopecia Therapeutics Business (2016-2021) & (US$ Million)
Table 96. Sun Pharma Recent Development
Table 97. Reddy's Laboratories Company Details
Table 98. Reddy's Laboratories Business Overview
Table 99. Reddy's Laboratories Revenue in Androgenic Alopecia Therapeutics Business (2016-2021) & (US$ Million)
Table 100. Reddy's Laboratories Recent Development
Table 101. Concert Pharmaceuticals Company Details
Table 102. Concert Pharmaceuticals Business Overview
Table 103. Concert Pharmaceuticals Androgenic Alopecia Therapeutics Product
Table 104. Concert Pharmaceuticals Revenue in Androgenic Alopecia Therapeutics Business (2016-2021) & (US$ Million)
Table 105. Concert Pharmaceuticals Recent Development
Table 106. RiverTown Therapeutics Company Details
Table 107. RiverTown Therapeutics Business Overview
Table 108. RiverTown Therapeutics Androgenic Alopecia Therapeutics Product
Table 109. RiverTown Therapeutics Revenue in Androgenic Alopecia Therapeutics Business (2016-2021) & (US$ Million)
Table 110. RiverTown Therapeutics Recent Development
Table 111. Brickell Biotech Company Details
Table 112. Brickell Biotech Business Overview
Table 113. Brickell Biotech Androgenic Alopecia Therapeutics Product
Table 114. Brickell Biotech Revenue in Androgenic Alopecia Therapeutics Business (2016-2021) & (US$ Million)
Table 115. Brickell Biotech Recent Development
Table 116. BiologicsMD Company Details
Table 117. BiologicsMD Business Overview
Table 118. BiologicsMD Androgenic Alopecia Therapeutics Product
Table 119. BiologicsMD Revenue in Androgenic Alopecia Therapeutics Business (2016-2021) & (US$ Million)
Table 120. BiologicsMD Recent Development
Table 121. Aclaris Therapeutics Company Details
Table 122. Aclaris Therapeutics Business Overview
Table 123. Aclaris Therapeutics Androgenic Alopecia Therapeutics Product
Table 124. Aclaris Therapeutics Revenue in Androgenic Alopecia Therapeutics Business (2016-2021) & (US$ Million)
Table 125. Aclaris Therapeutics Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Androgenic Alopecia Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Medicine Features
Figure 3. Surgery Features
Figure 4. Other Features
Figure 5. Global Androgenic Alopecia Therapeutics Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Clinic Case Studies
Figure 8. Other Case Studies
Figure 9. Androgenic Alopecia Therapeutics Report Years Considered
Figure 10. Global Androgenic Alopecia Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Androgenic Alopecia Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Androgenic Alopecia Therapeutics Market Share by Regions: 2020 VS 2027
Figure 13. Global Androgenic Alopecia Therapeutics Market Share by Regions (2022-2027)
Figure 14. Global Androgenic Alopecia Therapeutics Market Share by Players in 2020
Figure 15. Global Top Androgenic Alopecia Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Androgenic Alopecia Therapeutics as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Androgenic Alopecia Therapeutics Revenue in 2020
Figure 17. Global Androgenic Alopecia Therapeutics Revenue Market Share by Type (2016-2021)
Figure 18. Global Androgenic Alopecia Therapeutics Revenue Market Share by Type (2022-2027)
Figure 19. North America Androgenic Alopecia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Androgenic Alopecia Therapeutics Market Share by Type (2016-2027)
Figure 21. North America Androgenic Alopecia Therapeutics Market Share by Application (2016-2027)
Figure 22. North America Androgenic Alopecia Therapeutics Market Share by Country (2016-2027)
Figure 23. United States Androgenic Alopecia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Androgenic Alopecia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Androgenic Alopecia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Androgenic Alopecia Therapeutics Market Share by Type (2016-2027)
Figure 27. Europe Androgenic Alopecia Therapeutics Market Share by Application (2016-2027)
Figure 28. Europe Androgenic Alopecia Therapeutics Market Share by Country (2016-2027)
Figure 29. Germany Androgenic Alopecia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Androgenic Alopecia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Androgenic Alopecia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Androgenic Alopecia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Androgenic Alopecia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Androgenic Alopecia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Androgenic Alopecia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Androgenic Alopecia Therapeutics Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Androgenic Alopecia Therapeutics Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Androgenic Alopecia Therapeutics Market Share by Region (2016-2027)
Figure 39. China Androgenic Alopecia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Androgenic Alopecia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Androgenic Alopecia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Androgenic Alopecia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Androgenic Alopecia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Androgenic Alopecia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Androgenic Alopecia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Androgenic Alopecia Therapeutics Market Share by Type (2016-2027)
Figure 47. Latin America Androgenic Alopecia Therapeutics Market Share by Application (2016-2027)
Figure 48. Latin America Androgenic Alopecia Therapeutics Market Share by Country (2016-2027)
Figure 49. Mexico Androgenic Alopecia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Androgenic Alopecia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Androgenic Alopecia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Androgenic Alopecia Therapeutics Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Androgenic Alopecia Therapeutics Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Androgenic Alopecia Therapeutics Market Share by Country (2016-2027)
Figure 55. Turkey Androgenic Alopecia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Androgenic Alopecia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Androgenic Alopecia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Johnson & Johnson Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2016-2021)
Figure 59. Merck Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2016-2021)
Figure 60. GlaxoSmithKline Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2016-2021)
Figure 61. Astellas Pharma Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2016-2021)
Figure 62. Cipla Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2016-2021)
Figure 63. Almirall Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2016-2021)
Figure 64. Sun Pharma Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2016-2021)
Figure 65. Reddy's Laboratories Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2016-2021)
Figure 66. Concert Pharmaceuticals Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2016-2021)
Figure 67. RiverTown Therapeutics Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2016-2021)
Figure 68. Brickell Biotech Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2016-2021)
Figure 69. BiologicsMD Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2016-2021)
Figure 70. Aclaris Therapeutics Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

以下、関連資料のご紹介

世界の脱毛症幹細胞治療市場規模・現状・予測（2021年-2027年）

Global Stem Cell Alopecia Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4901 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、脱毛症幹細胞治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（円形脱毛症、全頭脱毛症、全身性脱毛症）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日...

世界の脱毛症幹細胞＆多血小板血漿（PRP）治療市場規模・現状・予測（2021年-2027年）

Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size, Status and Forecast 2021-2027
QFJ1-6020 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、脱毛症幹細胞＆多血小板血漿（PRP）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（多血小板血漿注射、幹細胞治療）、用途別市場規模（皮膚科クリニック、病院）、主要地域別市場規模（北米、アメリカ、欧...

世界のCOPD治療薬市場規模・現状・予測（2021年-2027年）

Global COPD Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-5676 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、COPD治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（気管支拡張薬、吸入コルチコステロイド、その他）、用途別市場規模（大人用、子供用）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界の脾腫治療薬市場規模・現状・予測（2021年-2027年）

Global Splenomegaly Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-6019 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、脾腫治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬物療法、予防接種、その他）、用途別市場規模（正常（非脾腫）、中等度脾腫、重度脾腫）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界の抗菌治療薬市場規模・現状・予測（2021年-2027年）

Global Antimicrobial Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-5586 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、抗菌治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（病院、診療所、個人、その他）、用途別市場規模（抗ウイルス剤、抗菌剤、抗真菌剤、駆虫剤）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本...

世界のアテローム性動脈硬化症治療薬市場規模・現状・予測（2021年-2027年）

Global Atherosclerosis Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-5602 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、アテローム性動脈硬化症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（小分子、生物製剤）、用途別市場規模（病院、診療所、研究機関、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本...

世界のアトピー性皮膚炎治療薬市場規模・現状・予測（2021年-2027年）

Global Atopic Dermatitis Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-3867 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、アトピー性皮膚炎治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（外用剤、全身療法）、用途別市場規模（大人用、子供用）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、...

世界の未分化甲状腺がん治療薬市場規模・現状・予測（2021年-2027年）

Global Anaplastic Thyroid Cancer Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-3802 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、未分化甲状腺がん治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東...

世界の咽頭がん治療薬市場規模・現状・予測（2021年-2027年）

Global Throat Cancer Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-6037 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、咽頭がん治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（手術、放射線療法、化学療法）、用途別市場規模（ショッピングセンター、病院、コミュニティ、その他）、主要地域別市場規模（北米、アメリカ、欧州...

世界のロタウイルス感染症治療薬市場規模・現状・予測（2021年-2027年）

Global Rotavirus Infection Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-4839 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、ロタウイルス感染症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口薬、注射薬）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界の脱毛症幹細胞治療市場規模・現状・予測（2021年-2027年） The stem cells, which are stimulated by the drug, replenish or restore cells associated with the induction of hair growth. Market Analysis and Insights: Global Stem Cell Alopecia Treatment Market The global Stem Cell Alopecia Treatment market size is projected to reach US$ XX million by 2027, from U…
世界の脱毛症幹細胞＆多血小板血漿（PRP）治療市場規模・現状・予測（2021年-2027年） Platelet-rich plasma (PRP) has emerged as a new treatment modality in regenerative plastic surgery, and preliminary evidence suggests that it might have a beneficial role in hair regrowth. Market Analysis and Insights: Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market The gl…
世界のアテローム性動脈硬化症治療薬市場規模・現状・予測（2021年-2027年） Atherosclerosis is a disease in which the inside of an artery narrows due to the build up of plaque. The identification of new drug targets for atherosclerosis will be one of the critical atherosclerosis therapeutics market trends driving the growth of the market. Although statins are regarded as th…
世界の動脈硬化症治療薬市場規模・現状・予測（2021年-2027年） Arteriosclerosis is a generalized thickening and stiffening of the arterial wall and is related to high blood pressure or hypertension. Market Analysis and Insights: Global Arteriosclerosis Therapeutics Market The global Arteriosclerosis Therapeutics market size is projected to reach US$ XX million …
世界の抗菌治療薬市場規模・現状・予測（2021年-2027年） An antimicrobial is an agent that kills microorganisms or stops their growth. The increasing prevalence of deadly diseases such as HIV and HPV has created the need for high-quality diagnostics which will enable early diagnosis of the infection. Technological advancements in the healthcare industry h…